NCT00115570View on ClinicalTrials.gov

Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

572

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Diabetes Mellitus, Insulin-Dependent
Interventions
DRUG

Insulin glulisine

Subcutaneous injection

DRUG

insulin lispro

Subcutaneous injection

DRUG

insulin glargine

Subcutaneous injection once daily

DRUG

NPH insulin

subcutaneous injection twice daily

Trial Locations (1)

15213

Childrens Hospital of Pittsburgh, Pittsburgh

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY